We are live on ! Find out more
BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

23 hedge funds and large institutions have $3.6M invested in ProShares Ultra NASDAQ Biotechnology in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

459% more call options, than puts

Call options by funds: $1.14M | Put options by funds: $204K

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

70% more capital invested

Capital invested by funds: $2.12M → $3.6M (+$1.48M)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

21% more funds holding

Funds holding: 19 → 23 (+4)

1.9% more ownership

Funds ownership: 2.53% → 4.43% (+1.9%)

Holders
23
Holders Change
+4
Holders Change %
+21.05%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
3
Closed
2
Calls
$1.14M
Puts
$204K
Net Calls
+$937K
Net Calls Change
+$227K

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$631K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$561K
3
CAG
Csenge Advisory Group
Florida
+$237K
4
ATPW
Ashton Thomas Private Wealth
Arizona
+$30.9K
5
DWP
Destiny Wealth Partners
Florida
+$22.4K

Top Sellers

1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$64K
2
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
-$16.3K
3
WT
Whittier Trust
California
-$4.97K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$249
5
Wells Fargo
Wells Fargo
California
-$83
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$1.08M +$561K +6,775 +105%
Citadel Advisors
2
Citadel Advisors
Florida
$620K +$631K +7,611 New
CIA
3
Capital Investment Advisors
Georgia
$489K – – –
KFS
4
Kaizen Financial Strategies
California
$483K +$20.7K +250 +5%
PWM
5
Palumbo Wealth Management
New York
$326K – – –
CAG
6
Csenge Advisory Group
Florida
$233K +$237K +2,856 New
TFA
7
Toth Financial Advisory
Virginia
$81.3K – – –
TRCT
8
Tower Research Capital (TRC)
New York
$80K +$3.65K +44 +5%
Franklin Resources
9
Franklin Resources
California
$56.7K – – –
PNC Financial Services Group
10
PNC Financial Services Group
Pennsylvania
$40.8K – – –
ATPW
11
Ashton Thomas Private Wealth
Arizona
$30.4K +$30.9K +373 New
DWP
12
Destiny Wealth Partners
Florida
$22K +$22.4K +270 New
MCM
13
MAI Capital Management
Ohio
$20.4K – – –
HIIFS
14
Harel Insurance Investments & Financial Services
Israel
$16K – – –
TC
15
Truvestments Capital
Florida
$10.2K – – –
Simplex Trading
16
Simplex Trading
Illinois
$5.05K +$4.14K +50 +417%
TWC
17
TD Waterhouse Canada
Ontario, Canada
$4.12K +$4.14K +50 New
Qube Research & Technologies (QRT)
18
Qube Research & Technologies (QRT)
United Kingdom
$4.08K -$249 -3 -6%
AIM
19
Axiom Investment Management
New York
$4.08K +$4.14K +50 New
WT
20
Whittier Trust
California
$1.22K -$4.97K -60 -80%
Morgan Stanley
21
Morgan Stanley
New York
$156 – – –
Wells Fargo
22
Wells Fargo
California
$89 -$83 -1 -50%
UBS Group
23
UBS Group
Switzerland
$82 – – –
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
– -$64K -800 Closed
Northwestern Mutual Wealth Management
25
Northwestern Mutual Wealth Management
Wisconsin
– -$16.3K -204 Closed

BIB Hedge Fund Activity: Q1 2026 in Review

23 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra NASDAQ Biotechnology (BIB) for Q1 2026, worth a combined $3.6M — up 70% from $2.12M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new BIB positions and 2 closed out — a net gain of 4 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $631K. The largest seller was Royal Bank of Canada, exiting entirely with an estimated $64K sold.

  • 23 institutional investors held ProShares Ultra NASDAQ Biotechnology (BIB) as of Q1 2026, up from 19 in Q4 2025.
  • Funds reported $3.6M of ProShares Ultra NASDAQ Biotechnology stock for Q1 2026, up 70% quarter-over-quarter.
  • 6 funds opened new ProShares Ultra NASDAQ Biotechnology positions in Q1 2026 and 2 closed out, a net change of +4 holders.
  • The largest ProShares Ultra NASDAQ Biotechnology buyer in Q1 2026 was Citadel Advisors, an estimated $631K added.
  • The largest ProShares Ultra NASDAQ Biotechnology seller in Q1 2026 was Royal Bank of Canada, an estimated $64K sold.

Based on aggregated 13F filings for Q1 2026.